Resumen de acción WAT
Waters Corporation ofrece soluciones de flujo de trabajo analítico en Asia, América y Europa.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 2/6 |
| Resultados anteriores | 2/6 |
| Salud financiera | 3/6 |
| Dividendos | 0/6 |
Competidores de Waters Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$290.30 |
| Máximo en 52 semanas | US$367.21 |
| Mínimo de 52 semanas | US$231.90 |
| Beta | 0.97 |
| 11 mes Cambio | -13.72% |
| Variación en 3 meses | -15.67% |
| Cambio de 1 año | 12.76% |
| 3Variación en 3 años | -16.00% |
| Variación en 5 años | 30.95% |
| Variación desde la OPV | 7,577.36% |
Noticias y actualizaciones recientes
Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price
May 26
Waters Corporation: Still Struggling A Bit
May 24Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 25Recent updates
Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price
May 26Waters Corporation: Still Struggling A Bit
May 24Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 25Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?
Apr 07We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt
Mar 19Waters Corporation: A Great (Share Price) Run
Mar 11Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323
Feb 09Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings
Jan 09Waters Corporation: High Quality Niche Company In Mass Spectrometry
Dec 28A Look At The Fair Value Of Waters Corporation (NYSE:WAT)
Dec 10Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Nov 25Waters Corporation: Appealing Levels Are Offset By Weaker Performance
Nov 13Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly
Oct 26Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)
Sep 27What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?
Aug 21Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Aug 03Waters Corporation: Temporary Headwinds Present A Buying Opportunity
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jul 16Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
May 23A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)
Apr 29Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly
Apr 08What Is Waters Corporation's (NYSE:WAT) Share Price Doing?
Feb 22Waters Q4 2022 Earnings Preview
Feb 14Waters Corp.: Now Best Price-Positioned Medical Services Stock
Feb 02Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 26Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?
Jan 05Should You Think About Buying Waters Corporation (NYSE:WAT) Now?
Nov 24Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363
Nov 16Waters Q3 2022 Earnings Preview
Oct 31Estimating The Fair Value Of Waters Corporation (NYSE:WAT)
Oct 19Waters announces €6M R&D investment at Wexford facility
Oct 07Is Waters (NYSE:WAT) Using Too Much Debt?
Oct 01Do Waters' (NYSE:WAT) Earnings Warrant Your Attention?
Aug 23Waters Corporation: Thesis Unchanged
Aug 18Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?
Aug 05Waters Non-GAAP EPS of $2.75 beats by $0.08, revenue of $714M beats by $7.23M
Aug 02Calculating The Fair Value Of Waters Corporation (NYSE:WAT)
Jul 18These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well
Jun 30Waters Corporation: Shares Are Getting Cheaper, But They Aren't Cheap Enough
Jun 01Here's Why We Think Waters (NYSE:WAT) Is Well Worth Watching
May 15Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?
Apr 29Waters Corporation (NYSE:WAT) Shares Could Be 22% Below Their Intrinsic Value Estimate
Apr 11Is Waters (NYSE:WAT) A Risky Investment?
Mar 25Waters Corporation: We Can Find Better Investments Out There
Mar 21If You Like EPS Growth Then Check Out Waters (NYSE:WAT) Before It's Too Late
Feb 03Rentabilidad de los accionistas
| WAT | US Life Sciences | Mercado US | |
|---|---|---|---|
| 7D | -1.4% | -1.5% | -0.3% |
| 1Y | 12.8% | 1.7% | 22.3% |
Rentabilidad vs. Industria: WAT superó a la industria US Life Sciences, que obtuvo un rendimiento del 0.8% el año pasado.
Rentabilidad vs. Mercado: WAT obtuvo unos resultados inferiores a los del mercado US, que fueron del 22.3% el año pasado.
Volatilidad de los precios
| WAT volatility | |
|---|---|
| WAT Average Weekly Movement | 4.2% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: WAT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de WAT (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1958 | 7,900 | Udit Batra | www.waters.com |
Waters Corporation ofrece soluciones de flujo de trabajo analítico en Asia, América y Europa. Opera a través de dos segmentos: Waters y TA. La empresa diseña, fabrica, vende y presta servicios de cromatografía líquida de alto y ultra rendimiento, así como sistemas de tecnología de espectrometría de masas (EM) y productos de apoyo, incluidas columnas de cromatografía, otros productos consumibles y planes de servicio posgarantía.
Resumen de fundamentos de Waters Corporation
| Estadísticas fundamentales de WAT | |
|---|---|
| Capitalización bursátil | US$17.02b |
| Beneficios(TTM) | US$603.51m |
| Ingresos (TTM) | US$2.91b |
28.5x
Ratio precio-beneficio (PE)5.9x
Ratio precio-ventas (PS)¿Está WAT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de WAT | |
|---|---|
| Ingresos | US$2.91b |
| Coste de los ingresos | US$1.17b |
| Beneficio bruto | US$1.74b |
| Otros gastos | US$1.13b |
| Beneficios | US$603.51m |
Últimos beneficios comunicados
Mar 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 10.17 |
| Margen bruto | 59.68% |
| Margen de beneficio neto | 20.75% |
| Ratio deuda/patrimonio | 164.0% |
¿Cómo se ha desempeñado WAT a largo plazo?
Ver rendimiento histórico y comparativa